Torrent Pharma Stock - Thursday technicals after FDA approval signal

Torrent Pharma stock is consolidating after a recent U.S. FDA approval for valsartan tablets, while Thursday’s trading shows the shares hovering just below their recent 52-week high. A look at the current chart picture and key levels on NSE.

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:29 CET. Details in the imprint.

Torrent Pharma (INE685A01028) is trading sideways on Thursday after a strong run-up in recent months. The shares are digesting a recent U.S. FDA approval for valsartan tablets that added to the company’s U.S. generics portfolio, according to a MarketNetra update.

What Thursday’s trading shows

On Thursday afternoon, Torrent Pharma shares changed hands around INR 4,443 on the National Stock Exchange of India, close to the prior close near INR 4,443 as reported by Bajaj Broking and MarketNetra. Bajaj Broking data indicates an intraday high of INR 4,496.40 and a low of INR 4,419.00.

Business Standard notes that the stock eased modestly, with a decline of about 0.4% on the day at mid-session, marking a fifth consecutive session of mild pressure on the quote. Business Standard coverage Over the past year, however, the stock has still delivered a gain close to 40%.

Chart levels and volatility picture

Data from Bajaj Broking show Torrent Pharma shares up roughly 36% over the last twelve months and about 1% in the past month, pointing to a consolidating trend after a strong run. Bajaj Broking data The price-to-earnings ratio stands near 68.7 as of 06/18/2026, underlining growth expectations embedded in the valuation.

The current quote remains not far below a 52-week high around INR 4,714 to INR 4,715, while the 52-week low is near INR 3,140 according to live Mint figures. Mint price overview Against this backdrop, the recent sideways phase looks more like a pause than a trend break, with volatility relatively muted compared with the prior rally.

How the company makes money

Torrent Pharma generates most of its revenue from branded generic pharmaceuticals in India and select international markets, with a presence in cardiovascular, central nervous system, gastrointestinal and anti-diabetic therapies. The company also exports formulations and active pharmaceutical ingredients to regulated markets, including the United States.

Where the stock trades today

The shares of Torrent Pharma (INE685A01028) trade on the National Stock Exchange of India at about INR 4,443.50 as of 06/18/2026, 15:30 IST.

Torrent Pharma stock at a glance

• Company: Torrent Pharmaceuticals Ltd
• ISIN: INE685A01028
• WKN: 500420
• Ticker: TORNTPHARM
• Venue: NSE
• Price (as of 06/18/2026, 15:30 IST): 4,443.50 INR
• Market cap: 1,51,000 crore INR (as of 06/18/2026)
• Sector / Industry: Pharmaceuticals / Branded generics
• Index membership: Nifty Pharma
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.